Deborah Geraghty, PhD

Dr. Geraghty joined Anokion in 2018 as Chief Business Officer and was most recently Chief Operating Officer of the company. Dr. Geraghty brings more than 20 years of extensive experience in the life sciences industry across corporate and portfolio strategy, commercial, and finance. Continue reading “Deborah Geraghty, PhD”

Laura Brass, PhD, MBA

Dr. Laura Brass is a Managing Director at NVF in Cambridge, MA, USA. Prior to joining NVF, Laura was a Managing Director at MPM Capital, and prior to that, she was a member of the founding management team and SVP of Business Development for TriNetX, a healthcare IT company focusing on big data analytics of live patient data for clinical research.  Continue reading “Laura Brass, PhD, MBA”

Harry Welten

Harry Welten, MBA, spent more than twenty years in international senior executive functions, sixtee of which as chief financial officer in biotechnology companies (privately as well as publicly held). Continue reading “Harry Welten”

Jeffrey Hubbell, PhD

Jeff is a professor and founder of the Institute of Bioengineering at the Ecole Polytechnique Fédérale de Lausanne (Swiss Federal Institute of Technology, EPFL), and a professor at the Institute of Molecular Engineering at the University of Chicago. Continue reading “Jeffrey Hubbell, PhD”